{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:59:10Z","timestamp":1769155150859,"version":"3.49.0"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Dysfunctional self-tolerance is thought to play a crucial role in the onset of rheumatoid arthritis (RA) pathogenesis. Poorly functioning regulatory T cells (Tregs) lead to extreme situations where self-tolerance is robustly disrupted. However, there are many uncertainties regarding its immunosuppressive pathways, especially concerning therapeutic drugs that are still in their infancy. Therefore, deciphering potential targets and developing novel drugs to ameliorate functional Tregs deficiency appears to be an efficient therapeutic approach for controlling RA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The therapeutic effects of EIE-2, a novel 3-arylbenzofuran derivative, were evaluated in collagen-induced arthritis (CIA) rats and carrageenan-induced paw edema mice <jats:italic>in vivo<\/jats:italic>, as well as in LPS-, PMA- or TNF-\u03b1-stimulated human CD4+ T cells (Jurkat), human synovial sarcoma cells (SW982) and primary isolated lymphocytes <jats:italic>in vitro<\/jats:italic>. The role of Syk in Treg-dependent tolerance and the mechanism of EIE-2 were explored using western blotting, quantitative reverse transcription PCR (qRT-PCR) and flow cytometry. Potential mechanistic targets were further validated through siRNA knockdown and molecular docking analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>EIE-2 significantly ameliorated arthritic symptoms and pathological damage in CIA rats by reducing pro-inflammatory cytokines and increasing anti-inflammatory factors in synovium and serum, and exhibited similar therapeutic effects in carrageenan-induced pedal edema mice. Moreover, EIE-2 potently suppressed the inflammatory responses in human synoviocyte SW982 cells, primary isolated lymphocytes and CD4+ Jurkat cells. Its therapeutic potential was associated with upregulation of Tregs during the active phase and downregulation during the inactive phase of RA. Mechanistically, EIE-2 modulated the PKC\u03b8\/mTOR ratio via Syk targeting, thereby restoring homeostasis in Tregs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>EIE-2 is a potential therapeutic candidate for RA. The underlying mechanism may involve its targeting on Syk to upregulate the PKC\u03b8\/mTOR ratio during the active phase of RA and downregulate the PKC\u03b8\/mTOR ratio during the inactive phase of RA, ultimately promoting Treg-dependent tolerance restoration.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1524491","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:14:25Z","timestamp":1747800865000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A new 3-arylbenzofuran derivative EIE-2 reestablishes Treg-dependent tolerance in rheumatoid arthritis by targeting on Syk induced mTOR and PKC\u03b8 imbalance"],"prefix":"10.3389","volume":"16","author":[{"given":"Ping","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinzhu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanqing","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunsuo","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingbao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","author":"Silman","year":"2002","journal-title":"Arthritis Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.101477","article-title":"The epidemiology of established rheumatoid arthritis","volume":"33","author":"Ot\u00f3n","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30761-3","article-title":"Tapering glucocorticoids in rheumatoid arthritis","volume":"396","author":"Volkmann","year":"2020","journal-title":"Lancet (London England)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.3390\/cells10123524","article-title":"From nsaids to glucocorticoids and beyond","volume":"10","author":"Sinniah","year":"2021","journal-title":"Cells"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113074","article-title":"Application and pharmacological mechanism of methotrexate in rheumatoid arthritis","volume":"150","author":"Zhao","year":"2022","journal-title":"Biomed Pharmacother = Biomedecine Pharmacotherapie"},{"key":"B7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00018-022-04563-0","article-title":"Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential","volume":"79","author":"Yan","year":"2022","journal-title":"Cell Mol Life Sci: CMLS"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet (London England)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04868-6","article-title":"Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities","volume":"41","author":"Muller","year":"2021","journal-title":"Rheumatol Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ni909","article-title":"An essential role for scurfin in cd4+Cd25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00657","article-title":"Immunoporosis: immunology of osteoporosis-role of T cells","volume":"9","author":"Srivastava","year":"2018","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.626193","article-title":"Function and role of regulatory T cells in rheumatoid arthritis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162306","article-title":"The proportion of regulatory T cells in patients with rheumatoid arthritis: A meta-analysis","volume":"11","author":"Morita","year":"2016","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.22034\/iji.2021.68100.1365","article-title":"Evaluation of Cd4+\/Cd25+\/high\/Cd127low\/- regulatory T Cells in rheumatoid arthritis patients","volume":"23","author":"Delavari","year":"2021","journal-title":"Iran J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0806855105","article-title":"Defects in ctla-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis","volume":"105","author":"Flores-Borja","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2012.696135","article-title":"Distribution of regulatory T cells and interaction with dendritic cells in the synovium of rheumatoid arthritis","volume":"41","author":"XQ","year":"2012","journal-title":"Scandinavian J Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109814","article-title":"Negative impact of interleukin-9 on synovial regulatory T cells in rheumatoid arthritis","volume":"257","author":"Chakraborty","year":"2023","journal-title":"Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"19789","DOI":"10.1038\/s41598-020-76168-1","article-title":"Inhibitory activity of foxp3+ Regulatory T cells reveals high specificity for displaying immune tolerance in remission state rheumatoid arthritis","volume":"10","author":"Kanjana","year":"2020","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213511","article-title":"Maresin 1 improves the Treg\/th17 imbalance in rheumatoid arthritis through mir-21","volume":"77","author":"Jin","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of cd4+Cd25+ Regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0324-7","article-title":"Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases","volume":"30","author":"Ohkura","year":"2020","journal-title":"Cell Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.27438","article-title":"Genetic deficiency of Syk protects mice from autoantibody-induced arthritis","volume":"62","author":"Jakus","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2174\/0113894501276093231206064243","article-title":"An update on the emerging role of wnt\/B-catenin, Syk, pi3k\/akt, and gm-csf signaling pathways in rheumatoid arthritis","volume":"24","author":"Prajapati","year":"2023","journal-title":"Curr Drug Targets"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/art.30109","article-title":"Syk kinase inhibitors for rheumatoid arthritis: trials and tribulations","volume":"63","author":"Boers","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1459562","article-title":"Splenic tyrosine kinase (Syk) inhibitors and their possible use in acute myeloid leukemia","volume":"27","author":"Bartaula-Brevik","year":"2018","journal-title":"Expert Opin Investigational Drugs"},{"key":"B26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imm.13178","article-title":"Control of regulatory T-cell differentiation and function by T-cell receptor signalling and foxp3 transcription factor complexes","volume":"160","author":"Ono","year":"2020","journal-title":"Immunology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102373","article-title":"The immunobiology of mtor in autoimmunity","volume":"110","author":"Suto","year":"2020","journal-title":"J Autoimmun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"16247","DOI":"10.1038\/s41598-018-34548-8","article-title":"Pma Inhibits Endothelial Cell Migration through Activating the Pkc-\u0394\/Syk\/Nf-Kb-Mediated up-Regulation of Thy-1","volume":"8","author":"Wen","year":"2018","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/biomedicines9091127","article-title":"The fc\u03b3riii engagement augments pma-stimulated neutrophil extracellular traps (Nets) formation by granulocytes partially via cross-talk between Syk-erk-nf-Kb and pkc-ros signaling pathways","volume":"9","author":"Lu","year":"2021","journal-title":"Biomedicines"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040999","article-title":"Pkc-dependent human monocyte adhesion requires ampk and Syk activation","volume":"7","author":"Chang","year":"2012","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.763624","article-title":"Perilla leaf extract (Ple) attenuates copd airway inflammation via the tlr4\/Syk\/pkc\/nf-Kb pathway in vivo and in vitro","volume":"12","author":"Yuan","year":"2021","journal-title":"Front Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.464107","article-title":"Tyrosine phosphorylation on spleen tyrosine kinase (Syk) is differentially regulated in human and murine platelets by protein kinase C isoforms","volume":"288","author":"Buitrago","year":"2013","journal-title":"J Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1042\/bst20140180","article-title":"Pkc\u03b8-regulated signalling in health and disease","volume":"42","author":"Nath","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2008.08.275","article-title":"Differential requirement of pkc-theta in the development and function of natural regulatory T cells","volume":"46","author":"Gupta","year":"2008","journal-title":"Mol Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-11-26","article-title":"Differential cytokine regulation by nf-kappab and ap-1 in Jurkat T-cells","volume":"11","author":"Khalaf","year":"2010","journal-title":"BMC Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.6.3593","article-title":"Molecular mechanisms underlying foxp3 induction in human T cells","volume":"176","author":"Mantel","year":"2006","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"v3","DOI":"10.1093\/rheumatology\/kes113","article-title":"Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis","author":"Choy","year":"2012","journal-title":"Rheumatol (Oxford England)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3085","article-title":"Phosphorylation of foxp3 controls regulatory T cell function and is inhibited by tnf-A in rheumatoid arthritis","volume":"19","author":"Nie","year":"2013","journal-title":"Nat Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.12659\/msm.895116","article-title":"Serum levels of il-6 and tnf-A May correlate with activity and severity of rheumatoid arthritis","volume":"21","author":"Wei","year":"2015","journal-title":"Med Sci Monitor"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7254.2006.00330.x","article-title":"Anti-inflammatory effect of amurensin H on asthma-like reaction induced by allergen in sensitized mice","volume":"27","author":"Li","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01157","article-title":"a derivative from resveratrol, ameliorates lipopolysaccharide\/cigarette smoke-induced airway inflammation by blocking the Syk\/nf-Kb pathway","volume":"10","author":"Fan","year":"2019","journal-title":"Front Pharmacol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14893","article-title":"Chondroprotective and anti-inflammatory effects of amurensin H by regulating tlr4\/Syk\/nf-Kb signals","volume":"24","author":"Ma","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms150917188","article-title":"A combined experimental and computational study of vam3, a derivative of resveratrol, and Syk interaction","volume":"15","author":"Jiang","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00538","article-title":"Tamarixinin a alleviates joint destruction of rheumatoid arthritis by blockade of mapk and nf-Kb activation","volume":"8","author":"Zhuang","year":"2017","journal-title":"Front Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/art.34398","article-title":"Regulation of inflammatory responses and fibroblast-like synoviocyte apoptosis by calcineurin-binding protein 1 in mice with collagen-induced arthritis","volume":"64","author":"Yi","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.9b00621","article-title":"Discovery of lanraplenib (Gs-9876): A once-daily spleen tyrosine kinase inhibitor for autoimmune diseases","volume":"11","author":"Blomgren","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat Protoc"},{"key":"B48","doi-asserted-by":"publisher","first-page":"16689","DOI":"10.1038\/s41598-022-20648-z","article-title":"Alloferon-1 ameliorates acute inflammatory responses in \u039b-carrageenan-induced paw edema in mice","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112711","article-title":"Effect of phenolic compounds from oenothera rosea on the kaolin-carrageenan induced arthritis model in mice","volume":"253","author":"Vargas-Ruiz","year":"2020","journal-title":"J\u00a0Ethnopharmacol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41584-020-00570-2","article-title":"Location, location, location: how the tissue microenvironment affects inflammation in ra","volume":"17","author":"Buckley","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0631-3","article-title":"Synovial cellular and molecular markers in rheumatoid arthritis","volume":"39","author":"Asif Amin","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/art.40504","article-title":"Review: synovial cell metabolism and chronic inflammation in rheumatoid arthritis","volume":"70","author":"Falconer","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","article-title":"Duality of fibroblast-like synoviocytes in ra: passive responders and imprinted aggressors","volume":"9","author":"Bottini","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3892\/mmr.2021.12194","article-title":"Ginkgolide J protects human synovial cells sw982 via suppression of P38\u2212Dependent production of pro\u2212Inflammatory mediators","volume":"24","author":"Zhao","year":"2021","journal-title":"Mol Med Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15707","article-title":"Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and il-1 receptor: preclinical and clinical evidence in osteoarthritis and gout","volume":"179","author":"Franco-Trepat","year":"2022","journal-title":"Br J Pharmacol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13075-019-2085-6","article-title":"Inhibition of nrf2\/ho-1 signaling leads to increased activation of the nlrp3 inflammasome in osteoarthritis","volume":"21","author":"Chen","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B57","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4567","article-title":"Tnf downmodulates the function of human cd4+Cd25hi T-regulatory cells","volume":"108","author":"Valencia","year":"2006","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/art.41134","article-title":"Involvement of tumor necrosis factor receptor type ii in foxp3 stability and as a marker of Treg cells specifically expanded by anti-tumor necrosis factor treatments in rheumatoid arthritis","volume":"72","author":"Santinon","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/art.34565","article-title":"Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy","volume":"64","author":"McGovern","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2012.09.001","article-title":"Anti-tnf-A Therapy improves Treg and suppresses teff in patients with rheumatoid arthritis","volume":"279","author":"Huang","year":"2012","journal-title":"Cell Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108793","article-title":"Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis","volume":"230","author":"Liu","year":"2021","journal-title":"Clin Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1021\/jm201271b","article-title":"Discovery and development of spleen tyrosine kinase (Syk) inhibitors","volume":"55","author":"Singh","year":"2012","journal-title":"J Med Chem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175463","article-title":"Protein kinase C theta is dispensable for suppression mediated by cd25+Cd4+ Regulatory T cells","volume":"12","author":"Siegmund","year":"2017","journal-title":"PloS One"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2217\/imt.14.84","article-title":"Mtor signaling, Tregs and immune modulation","volume":"6","author":"Chapman","year":"2014","journal-title":"Immunotherapy"},{"key":"B66","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/cells7100161","article-title":"Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development","volume":"7","author":"Yap","year":"2018","journal-title":"Cells"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.715894","article-title":"Critical role of synovial tissue-resident macrophage and fibroblast subsets in the persistence of joint inflammation","volume":"12","author":"Kemble","year":"2021","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"10922","DOI":"10.3390\/ijms222010922","article-title":"Cytokine networks in the pathogenesis of rheumatoid arthritis","volume":"22","author":"Kondo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.183","article-title":"Regulatory T cells as therapeutic targets in rheumatoid arthritis","volume":"5","author":"Esensten","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118463","article-title":"Wutou decoction alleviates arthritis inflammation in cia mice by regulating Treg cell stability and Treg\/th17 balance via the jak2\/stat3 pathway","volume":"334","author":"Han","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2014.07.028","article-title":"Clematichinenoside ar induces immunosuppression involving Treg cells in Peyer\u2019s patches of rats with adjuvant induced arthritis","volume":"155","author":"Xiong","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2019.111091","article-title":"Immune th17 lymphocytes play a critical role in the multiple beneficial properties of resveratrol","volume":"137","author":"Delmas","year":"2020","journal-title":"Food Chem Toxicol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.3390\/ijms25052688","article-title":"Osteoimmunology: the crosstalk between T cells, B cells, and osteoclasts in rheumatoid arthritis","volume":"25","author":"Yang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1710-0","article-title":"The th17\/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis","volume":"32","author":"Wang","year":"2012","journal-title":"Rheumatol Int"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200205000-00002","article-title":"Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases","volume":"14","author":"Criscione","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223357","article-title":"Safety of synthetic and biological dmards: A systematic literature review informing the 2022 update of the eular recommendations for the management of rheumatoid arthritis","volume":"82","author":"Sepriano","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105618","article-title":"Phytochemical add-on therapy to dmards therapy in rheumatoid arthritis: in vitro and in vivo bases, clinical evidence and future trends","volume":"169","author":"Kour","year":"2021","journal-title":"Pharmacol Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.3.1886","article-title":"Pkc-theta-deficient mice are protected from th1-dependent antigen-induced arthritis","volume":"177","author":"Healy","year":"2006","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.immuni.2017.11.008","article-title":"Roquin suppresses the pi3k-mtor signaling pathway to inhibit T helper cell differentiation and conversion of Treg to tfr cells","volume":"47","author":"Essig","year":"2017","journal-title":"Immunity"},{"key":"B80","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/b978-0-12-404717-4.00006-8","article-title":"The yin and yang of protein kinase C-theta (Pkc\u03b8): A novel drug target for selective immunosuppression","volume":"66","author":"Zhang","year":"2013","journal-title":"Adv Pharmacol (San Diego Calif)"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1122063","article-title":"T regulatory cells metabolism: the influence on functional properties and treatment potential","volume":"14","author":"Tomaszewicz","year":"2023","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/cs20110631","article-title":"Up-regulation of foxp3 and induction of suppressive function in cd4+ Jurkat T-cells expressing hepatitis C virus core protein","volume":"123","author":"Dominguez-Villar","year":"2012","journal-title":"Clin Sci (London England: 1979)"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.08.006","article-title":"The ubiquitin ligase stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor foxp3","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050308","article-title":"The deubiquitinase usp44 promotes Treg function during inflammation by preventing foxp3 degradation","volume":"21","author":"Yang","year":"2020","journal-title":"EMBO Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1524491\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:14:26Z","timestamp":1747800866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1524491\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":84,"alternative-id":["10.3389\/fimmu.2025.1524491"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1524491","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"article-number":"1524491"}}